knowledge -WSS

knowledge

author：entertainment 2025-09-28 07:28:51 Page View：17

close-up of psoriasis on a hand. -- biotech coverage from STAT — A close-up of psoriasis on a hand. Adobe

San Francisco startup Alumis Inc. has raised $259 million in a bid to best big pharma’s work in plaque psoriasis.

Alumis announced its Series C round Wednesday and plans to move its lead drug into Phase 3 trials. Venture firm Foresite Capital, which incubated Alumis, co-led the financing with Samsara BioCapital and venBio Partners.

Alumis’ lead drug, ESK-001, is an oral medicine designed to help patients with the most common type of psoriasis by inhibiting a signaling protein called TYK2. Research has shown that the TYK2 protein plays a role in diseases where the immune system overreacts, which has made it a popular drug target in recent years.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Virtual repurposing can help discover new uses for existing drugs
Next article： Anesthesiologist group: stop taking Ozempic before surgery

explore

How one medical school became remarkably diverse

ThefirstclassattheUniversityofCalifornia,Davismedicalschool,in1972,waspredominantlywhiteandmale.Chri

Personalized medicine goes far beyond genetics

AdobeSincetheHumanGenomeProjectwascompletedin2003,mostpublicconsiderationsofpersonalizedmedicinehave

Hepatitis C has a cure — but many Americans still lack access to it

AdobeIn2005,NickVoyleswasdiagnosedwithhepatitisCafterbeingreleasedfromfiveyearsofincarceration.Anurs

FAA sets up new process for Hawaii air tour operators to fly at lower altitudes after fatal crashes

HONOLULU--TheFederalAviationAdministrationsaidFridaythatitissettingupanewprocessforairtouroperatorsi